• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载还原氧化石墨烯的多组分水凝胶微珠用于多种药物的pH响应型可控共递送

Multi-Component Hydrogel Beads Incorporated with Reduced Graphene Oxide for pH-Responsive and Controlled Co-Delivery of Multiple Agents.

作者信息

Obireddy Sreekanth Reddy, Lai Wing-Fu

机构信息

Department of Chemistry, Sri Krishnadevaraya University, Ananthapuramu 515003, India.

Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China.

出版信息

Pharmaceutics. 2021 Feb 28;13(3):313. doi: 10.3390/pharmaceutics13030313.

DOI:10.3390/pharmaceutics13030313
PMID:33670952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7997452/
Abstract

The development of combination therapy has received great attention in recent years because of its potential to achieve higher therapeutic efficacy than that achieved by mono-drug therapy. Carriers for effective and stimuli-responsive co-delivery of multiple agents, however, are highly deficient at the moment. To address this need, this study reports the generation of multi-component hydrogel beads incorporated with reduced graphene oxide (rGO). The beads are prepared by incorporating doxorubicin (DOX)-loaded gelatine (GL) microbeads into hydrogel beads containing rGO and 5-fluorouracil (5-FU). rGO-containing beads are shown to be more effective in inhibiting the growth of MCF-7 cells via the induction of reactive oxygen species (ROS) generation. In addition, the drug release sustainability of the beads is affected by the pH of the release medium, with the release rate increasing in neutral pH but decreasing in the acidic environment. Our beads warrant further development as carriers for pH-responsive and controlled co-delivery of multiple agents.

摘要

近年来,联合疗法的发展备受关注,因为它有可能实现比单一药物疗法更高的治疗效果。然而,目前用于有效且对刺激有响应的多种药物共递送的载体严重不足。为满足这一需求,本研究报道了一种包含还原氧化石墨烯(rGO)的多组分水凝胶珠的制备。这些珠子是通过将负载阿霉素(DOX)的明胶(GL)微珠掺入含有rGO和5-氟尿嘧啶(5-FU)的水凝胶珠中制备而成。含rGO的珠子通过诱导活性氧(ROS)生成,在抑制MCF-7细胞生长方面显示出更高的有效性。此外,珠子的药物释放可持续性受释放介质pH值的影响,在中性pH值下释放速率增加,而在酸性环境中降低。我们的珠子有望进一步发展成为用于多种药物pH响应性和可控共递送的载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/0cbb673ed19a/pharmaceutics-13-00313-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/757cdec831ab/pharmaceutics-13-00313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/4acbe17f84d4/pharmaceutics-13-00313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/a78e02ffa40c/pharmaceutics-13-00313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/efb48a08a35e/pharmaceutics-13-00313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/9e3d3ee70411/pharmaceutics-13-00313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/41aeca5e5bfd/pharmaceutics-13-00313-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/2d24d4416ea6/pharmaceutics-13-00313-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/bf990efb5ebb/pharmaceutics-13-00313-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/0cbb673ed19a/pharmaceutics-13-00313-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/757cdec831ab/pharmaceutics-13-00313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/4acbe17f84d4/pharmaceutics-13-00313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/a78e02ffa40c/pharmaceutics-13-00313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/efb48a08a35e/pharmaceutics-13-00313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/9e3d3ee70411/pharmaceutics-13-00313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/41aeca5e5bfd/pharmaceutics-13-00313-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/2d24d4416ea6/pharmaceutics-13-00313-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/bf990efb5ebb/pharmaceutics-13-00313-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2774/7997452/0cbb673ed19a/pharmaceutics-13-00313-g009.jpg

相似文献

1
Multi-Component Hydrogel Beads Incorporated with Reduced Graphene Oxide for pH-Responsive and Controlled Co-Delivery of Multiple Agents.负载还原氧化石墨烯的多组分水凝胶微珠用于多种药物的pH响应型可控共递送
Pharmaceutics. 2021 Feb 28;13(3):313. doi: 10.3390/pharmaceutics13030313.
2
ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy.ROS 生成、pH 响应和高度可调的还原氧化石墨烯嵌入微球,具有内在的抗癌特性和多药物共递送能力,用于联合癌症治疗。
Drug Deliv. 2022 Dec;29(1):2481-2490. doi: 10.1080/10717544.2022.2100512.
3
γ-Radiation induced L-glutamic acid grafted highly porous, pH-responsive chitosan hydrogel beads: A smart and biocompatible vehicle for controlled anti-cancer drug delivery.γ-射线引发的 L-谷氨酸接枝高多孔、pH 响应性壳聚糖水凝胶珠:一种用于控制抗癌药物释放的智能和生物相容性载体。
Int J Biol Macromol. 2021 Jul 1;182:37-50. doi: 10.1016/j.ijbiomac.2021.03.134. Epub 2021 Mar 26.
4
Fabrication of a microfluidic device for studying the in situ drug-loading/release behavior of graphene oxide-encapsulated hydrogel beads.用于研究氧化石墨烯包裹水凝胶珠原位载药/释药行为的微流控装置的制备
Biomater Res. 2018 Mar 13;22:7. doi: 10.1186/s40824-018-0119-9. eCollection 2018.
5
Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.还原氧化石墨烯(rGO)杂化水凝胶作为近红外(NIR)/pH 双响应平台用于联合化学-光热治疗。
J Colloid Interface Sci. 2019 Feb 15;536:160-170. doi: 10.1016/j.jcis.2018.10.050. Epub 2018 Oct 19.
6
Carboxymethyl cellulose/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent.羧甲基纤维素/氧化石墨烯生物纳米复合水凝胶珠作为抗癌药物载体。
Carbohydr Polym. 2017 Jul 15;168:320-326. doi: 10.1016/j.carbpol.2017.03.014. Epub 2017 Mar 8.
7
Natural Polymer-Based Graphene Oxide Bio-nanocomposite Hydrogel Beads: Superstructures with Advanced Potentials for Drug Delivery.基于天然聚合物的氧化石墨烯生物纳米复合水凝胶珠:具有药物递送先进潜力的超结构
AAPS PharmSciTech. 2022 Nov 17;23(8):304. doi: 10.1208/s12249-022-02456-w.
8
Chitosan derivatives/reduced graphene oxide/alginate beads for small-molecule drug delivery.用于小分子药物递送的壳聚糖衍生物/还原氧化石墨烯/海藻酸盐珠粒
Mater Sci Eng C Mater Biol Appl. 2016 Dec 1;69:1222-8. doi: 10.1016/j.msec.2016.08.036. Epub 2016 Aug 14.
9
Preparation of spherical porous hydrogel beads based on ion-crosslinked gum tragacanth and graphene oxide: Study of drug delivery behavior.基于离子交联黄蓍胶和氧化石墨烯的球形多孔水凝胶珠的制备:药物输送行为的研究。
Carbohydr Polym. 2018 Aug 15;194:34-42. doi: 10.1016/j.carbpol.2018.04.022. Epub 2018 Apr 5.
10
Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy.透明质酸修饰的、IR780 偶联的、载多柔比星的还原氧化石墨烯用于靶向癌症化疗/光热/光动力治疗。
Biomater Adv. 2022 May;136:212764. doi: 10.1016/j.bioadv.2022.212764. Epub 2022 Mar 17.

引用本文的文献

1
Folate-Functionalized CS/rGO/NiO Nanocomposites as a Multifunctional Drug Carrier with Anti-Microbial, Target-Specific, and Stimuli-Responsive Capacities.叶酸功能化的壳聚糖/还原氧化石墨烯/氧化镍纳米复合材料作为一种具有抗菌、靶向特异性和刺激响应能力的多功能药物载体。
Int J Nanomedicine. 2025 Feb 14;20:1965-1981. doi: 10.2147/IJN.S489418. eCollection 2025.
2
Kinetics and Optimization Studies of Controlled 5-Fluorouracil Release from Graphene Oxide Incorporated Vegetable Oil-Based Polyurethane Composite Film.氧化石墨烯复合植物油基聚氨酯复合膜中5-氟尿嘧啶控释的动力学与优化研究
ACS Omega. 2024 Nov 18;9(48):47395-47409. doi: 10.1021/acsomega.4c02247. eCollection 2024 Dec 3.
3

本文引用的文献

1
Curcumin encapsulated dual cross linked sodium alginate/montmorillonite polymeric composite beads for controlled drug delivery.用于控释给药的姜黄素包封双交联海藻酸钠/蒙脱石聚合物复合珠
J Pharm Anal. 2021 Apr;11(2):191-199. doi: 10.1016/j.jpha.2020.07.002. Epub 2020 Aug 4.
2
Alginate-based complex fibers with the Janus morphology for controlled release of co-delivered drugs.具有Janus形态的藻酸盐基复合纤维用于共递送药物的控释。
Asian J Pharm Sci. 2021 Jan;16(1):77-85. doi: 10.1016/j.ajps.2020.05.003. Epub 2020 Jun 25.
3
Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
Novel -derived nanoliposomes enhance the inhibition of MCF-7 breast cancer cells by superb intracellular uptake of doxorubicin.
新型纳米脂质体通过阿霉素卓越的细胞内摄取增强了对MCF-7乳腺癌细胞的抑制作用。
Heliyon. 2024 Sep 26;10(19):e38337. doi: 10.1016/j.heliyon.2024.e38337. eCollection 2024 Oct 15.
4
Therapeutic strategy of biological macromolecules based natural bioactive compounds of diabetes mellitus and future perspectives: A systematic review.基于生物大分子的糖尿病天然生物活性化合物治疗策略及未来展望:一项系统综述
Heliyon. 2024 Jan 7;10(2):e24207. doi: 10.1016/j.heliyon.2024.e24207. eCollection 2024 Jan 30.
5
Three-Dimensional Printing Multi-Drug Delivery Core/Shell Fiber Systems with Designed Release Capability.具有设计释放能力的三维打印多药物递送核/壳纤维系统。
Pharmaceutics. 2023 Sep 18;15(9):2336. doi: 10.3390/pharmaceutics15092336.
6
Reduction-Responsive Chitosan-Based Injectable Hydrogels for Enhanced Anticancer Therapy.用于增强抗癌治疗的还原响应性壳聚糖基可注射水凝胶
Pharmaceuticals (Basel). 2023 Jun 5;16(6):841. doi: 10.3390/ph16060841.
7
Alkali metal-doped borospherenes M@CB (M = K, Na, and Li) as a highly efficient alternative for the drug delivery.碱金属掺杂硼笼 M@CB(M = K、Na 和 Li)作为药物输送的高效替代品。
J Mol Model. 2023 Apr 17;29(5):147. doi: 10.1007/s00894-023-05548-x.
8
Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform.聚合物纳米粒子作为生物兼容平台在脑癌和神经退行性疾病治疗中的应用。
Molecules. 2023 Jan 14;28(2):841. doi: 10.3390/molecules28020841.
9
Injectable PTHF-based thermogelling polyurethane implants for long-term intraocular application.用于长期眼内应用的基于聚四氢呋喃的可注射热凝胶聚氨酯植入物。
Biomater Res. 2022 Dec 2;26(1):70. doi: 10.1186/s40824-022-00316-z.
10
Assessing the Efficiency of Triangular Gold Nanoparticles as NIR Photothermal Agents In Vitro and Melanoma Tumor Model.评估三角形金纳米颗粒作为近红外光热试剂的体外和黑素瘤肿瘤模型的效率。
Int J Mol Sci. 2022 Nov 8;23(22):13724. doi: 10.3390/ijms232213724.
通过载有亲和体-DNA 杂合链的金纳米颗粒共递 5-氟尿嘧啶脱氧核苷和阿霉素,用于过表达 HER2 的乳腺癌的靶向协同化疗。
Sci Rep. 2020 Dec 16;10(1):22015. doi: 10.1038/s41598-020-79125-0.
4
Functionalized Graphene Oxide for Chemotherapeutic Drug Delivery and Cancer Treatment: A Promising Material in Nanomedicine.功能化氧化石墨烯用于化疗药物递送和癌症治疗:纳米医学中的一种有前途的材料。
Int J Mol Sci. 2020 Aug 30;21(17):6280. doi: 10.3390/ijms21176280.
5
Flexible heteroionic calcium-magnesium alginate beads for controlled drug release.柔性杂离子型钙镁藻酸盐珠用于控制药物释放。
Carbohydr Polym. 2019 Mar 1;207:224-229. doi: 10.1016/j.carbpol.2018.11.096. Epub 2018 Nov 30.
6
Recent progress of functionalised graphene oxide in cancer therapy.功能化氧化石墨烯在癌症治疗中的最新进展。
J Drug Target. 2019 Feb;27(2):125-144. doi: 10.1080/1061186X.2018.1474359. Epub 2018 Jun 17.
7
Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.用于将MCL1 siRNA高效叶酸介导递送至活化巨噬细胞的中性聚乙二醇化脂质体制剂。
Colloids Surf B Biointerfaces. 2017 Jul 1;155:459-465. doi: 10.1016/j.colsurfb.2017.04.023. Epub 2017 Apr 13.
8
In vivo tumor targeting and biodistribution evaluation of paramagnetic solid lipid nanoparticles for magnetic resonance imaging.用于磁共振成像的顺磁性固体脂质纳米粒的体内肿瘤靶向性及生物分布评估
Nanomedicine. 2017 Feb;13(2):693-700. doi: 10.1016/j.nano.2016.09.012. Epub 2016 Oct 5.
9
Multicompartment Microgel Beads for Co-Delivery of Multiple Drugs at Individual Release Rates.用于以个体释放速率共递送多种药物的多室微凝胶珠。
ACS Appl Mater Interfaces. 2016 Jan 13;8(1):871-80. doi: 10.1021/acsami.5b10274. Epub 2015 Dec 31.
10
Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery.绿色合成还原氧化石墨烯:评估其作为 pH 敏感药物载体的应用。
Int J Pharm. 2015 Dec 30;496(2):984-92. doi: 10.1016/j.ijpharm.2015.10.081. Epub 2015 Nov 2.